ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,999Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 337

$516K Total Retail Price of All Prescriptions

Rank: 69 out of 337

626 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 626 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 626 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 13,042 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
METOPROLOL TARTRATE 891 871 1 6
TRIAMTERENE-HCTZ 797 725 10 2 39
ATORVASTATIN CALCIUM 732 696 3 7
AMLODIPINE BESYLATE 648 602 4 3
SIMVASTATIN 608 574 5 1
LISINOPRIL 425 406 6 2
HYDROCHLOROTHIAZIDE 401 381 7 9
METFORMIN HCL 401 375 7 12
LEVOTHYROXINE SODIUM 396 365 9 5
OMEPRAZOLE 380 348 10 4
QUINAPRIL HCL 327 327 11 50
FUROSEMIDE 294 291 12 8
LOVASTATIN 239 227 13 24
ATENOLOL 232 231 14 10
LIPITOR 222 211 15 33
WARFARIN SODIUM 183 183 16 11
ALPRAZOLAM 177 164 17 78
CITALOPRAM HBR 175 150 18 17
GLIPIZIDE ER 153 127 19 69
HYDROCODONE-ACETAMINOPHEN 149 125 S3 20 13
KLOR-CON M20 148 148 21 65
AZITHROMYCIN 144 125 22 51
VERAPAMIL ER 136 136 23 77
ALLOPURINOL 134 134 24 28
ZOLPIDEM TARTRATE 129 119 25 23
LOSARTAN POTASSIUM 121 121 26 15
TRAMADOL HCL 118 102 27 32
CYMBALTA 115 73 28 59
TAMSULOSIN HCL 108 97 29 25
PROPRANOLOL HCL 105 81 30 121
NAPROXEN 103 91 31 98
TRIAMTERENE-HYDROCHLOROTHIAZID 102 99 32 272
DONEPEZIL HCL 97 97 33 22
AMITRIPTYLINE HCL 97 88 R 33 75
SYNTHROID 93 93 35 41
SERTRALINE HCL 92 75 36 18
DIOVAN 88 88 37 26
PAROXETINE HCL 87 59 38 46
CAPTOPRIL 80 69 39 204
JANUVIA 76 76 40 81
METOPROLOL SUCCINATE 74 74 41 21
AMOXICILLIN 74 64 41 193
GLYBURIDE 73 73 R 43 53
CIPROFLOXACIN HCL 73 64 43 71
GLIPIZIDE XL 72 72 45 123
CRESTOR 71 71 46 29
COLCRYS 68 65 47 128
PANTOPRAZOLE SODIUM 67 64 48 36
CLOPIDOGREL 66 66 49 42
ALENDRONATE SODIUM 65 65 50 19
ESCITALOPRAM OXALATE 64 55 51 66
DIGOXIN 63 63 52 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 58 53 139
TRAZODONE HCL 58 57 54 16
NEXIUM 54 44 55 56
PRAVASTATIN SODIUM 53 43 56 14
FLUTICASONE PROPIONATE 52 44 57 34
GABAPENTIN 52 52 57 20
GLYBURIDE-METFORMIN HCL 52 52 R 57 99
ADVAIR DISKUS 51 51 60 44
PLAVIX 50 50 61 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.